Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ana Clopés-Estela
Observed names:
A Clopes,
A Clopés,
A. Clopes,
A. Clopés,
Ana Clopes,
Ana Clopès,
Ana Clopés
show all 7
Institutions:
Institut d'Investigació Biomédica de Bellvitge,
Universitat Ramon Llull,
Universitat de Barcelona
Observed institutions:
Universitat Autònoma de Barcelona,
Hospital de Sant Pau,
Institut d'Investigació Biomédica de Bellvitge,
Institut Català d'Oncologia,
Duran i Reynals Hospital,
Universitat Ramon Llull,
Universitat de Barcelona
show all 7
ORCID:
0000-0002-1857-362X
Observed ORCID:
0000-0002-1857-362X
OpenAlex ID:
A5002680850
Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)
2016
·
Gemma Binefa
, Montse Garcia
, et al.
·
Scientific Reports
·
54
PDF
Financial consequences of a payment-by-results scheme in Catalonia: gefitinib in advanced EGFR-mutation positive non-small-cell lung cancer
2016
·
Ana Clopes
, Montse Gasol
, et al.
·
Journal of Medical Economics
·
40
PDF
Mouth-washings with recombinant human granulocyte–macrophage colony stimulating factor (rhGM-CSF) do not improve grade III–IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study
2002
·
D Valcárcel
, MA Sanz
, et al.
·
Bone Marrow Transplantation
·
35
Reduced-Intensity Conditioning Allogeneic Blood Stem Cell Transplantation with Fludarabine and Oral Busulfan with or without Pharmacokinetically Targeted Busulfan Dosing in Patients with Myeloid Leukemia Ineligible for Conventional Conditioning
2005
·
Rodrigo Martino
, José A. Pérez-Simón
, et al.
·
Transplantation and Cellular Therapy
·
29
Abstracts of posters
1994
·
L. Suffisseau
, M. C. Taugourdeau
, et al.
·
Pharmacy World & Science
·
24
Real‐world treatment outcomes of medicines used in special situations (off‐label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution
2023
·
Sandra Fontanals
, Anna Esteve
, et al.
·
Cancer Medicine
·
16
PDF
Implementing Risk-Sharing Arrangements for Innovative Medicines: The Experience in Catalonia (Spain)
2021
·
Laura Guarga
, Montse Gasol
, et al.
·
Value in Health
·
16
PDF
Posicionamiento del farmacéutico de hospital ante la utilización de medicamentos en condiciones diferentes a las autorizadas
2009
·
Olga Delgado
, Francesc Puigventós
, et al.
·
Farmacia Hospitalaria
·
16
Impacto presupuestario de los nuevos fármacos para el tratamiento del cáncer colorrectal
2007
·
M. Julieta Corral
, Ana Clopès
, et al.
·
Medicina Clínica
·
16
Absence of veno‐occlussive disease in a cohort of multiple myeloma patients undergoing autologous stem cell transplantation with targeted busulfan dosage
2006
·
A. Clopés
, A. Sureda
, et al.
·
European Journal Of Haematology
·
16
DPYD Genotyping, Fluoropyrimidine Dosage and Toxicity: An Umbrella Review of Systematic Reviews
2025
·
Sara Otero-Torres
, Rosa Rodríguez-Mauriz
, et al.
·
Pharmaceuticals
·
15
PDF
Description of controlled trials published in Methods and Findings, 1979-2002.
2006
·
J M Garcia-Alamino
, C Perrotta
, et al.
·
PubMed
·
12
Comments on “Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines”
2023
·
C. Ibáñez
, S. Fontanals
, et al.
·
ESMO Open
·
5
Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation
2013
·
Isabel Sánchez-Ortega
, Beatriz Patiño
, et al.
·
Journal of Medical Economics
·
5
PDF
Trasplante alogénico de progenitores hematopoyéticos con acondicionamiento no mieloablativo en régimen ambulatorio. Primera experiencia en España
2001
·
Antonio Salar
, Rodrigo Martino
, et al.
·
Medicina Clínica
·
5
Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project)
2024
·
Eduard Fort-Casamartina
, Sonia Pernas
, et al.
·
Journal of Clinical Medicine
·
4
PDF
Centralization and automation of non-toxic drug reconstitution in the pharmacy: a strengths, weaknesses, opportunities, and threats analysis
2023
·
Mirjam Crul
, Carlo Polidori
, et al.
·
International Journal of Pharmacy Practice
·
4
PDF
Evaluation Of A Payment By Results Scheme In A Catalan Cancer Center: Gefinitib In Egfr Mutation-Positive Advanced Non-Small Cell Lung Cancer
2015
·
S Simon
, A Clopes
, et al.
·
Value in Health
·
3
A phase I clinical and pharmacokinetic study (LIPOTEC - GP PHARM/DOXO 01) of a new liposomal doxorubicin given as 3-week schedule in patients with solid tumors
2009
·
Margarita Majem
, Ramon Salazar
, et al.
·
Journal of Liposome Research
·
3
Clinical practice guidelines for the optimization of hemato-oncological care: the ICOPraxis
2022
·
Consuelo Jordán de Luna
, Esteve Fernández
, et al.
·
Clinical & Translational Oncology
·
2
Simultaneous determination of five cytotoxic drugs in surface wiped samples using liquid chromatography and tandem mass spectrometry for the control of environmental contamination in a comprehensive cancer centre
2022
·
Núria Gonzalo
, Montse Rey
, et al.
·
International Journal of Environmental & Analytical Chemistry
·
2
COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain
2022
·
Paula Peremiquel-Trillas
, Anna Saura-Lázaro
, et al.
·
BMJ Open
·
2
PDF
Nous reptes i noves oportunitats de gestió dels medicaments a l'Institut Català d'Oncologia (ICO): la cerca de la col.laboració pública-privada en l'entorn del medicament
2014
·
Candela Calle
, Ana Clopés
, et al.
·
Annals de Medicina
·
2
Cost utility analysis of nab-paclitaxel weekly or q3w compared with docetaxel q3w as first-line therapy in metastatic breast cancer (MBC).
2010
·
G. Dranitsaris
, M. Perayre Badia
, et al.
·
Journal of Clinical Oncology
·
2
[Translated article] Characteristics, clinical benefit, and reimbursement of new authorisations for oncohaematology drugs in Spain between 2017 and 2020
2024
·
Hilario Martínez-Barros
, Álvaro Pousada-Fonseca
, et al.
·
Farmacia Hospitalaria
·
1
Show more works
View as search
Works count:
38
Citation count:
333
H-index:
12
I10-index:
12
Year
Topic
Type